The inhibition of kinases has been pursued by the pharmaceutical industry for over 20 years. While the locations of the sites that bind type II and III inhibitors at or near the adenosine 5'-triphosphate binding sites are well defined, the literature describes 10 different regions that were reported as regulatory hot spots in some kinases and thus are potential target sites for type IV inhibitors. Kinase Atlas is a systematic collection of binding hot spots located at the above ten sites in 4910 structures of 376 distinct kinases available in the Protein Data Bank. The hot spots are identified by FTMap, a computational analogue of experimental fragment screening. Users of Kinase Atlas ( https://kinase-atlas.bu.edu ) may view summarized results for all structures of a particular kinase, such as which binding sites are present and how druggable they are, or they may view hot spot information for a particular kinase structure of interest.
The inhibition of kinases has been pursued by the pharmaceutical industry for over 20 years. While the locations of the sites that bind type II and III inhibitors at or near the n class="Chemical">adenosine 5'-triphosphate binding sites are well defined, the literature describes 10 different regions that were reported as regulatory hot spots in some kinases and thus are potential target sites for type IV inhibitors. Kinase Atlas is a systematic collection of binding hot spots located at the above ten sites in 4910 structures of 376 distinct kinases available in the Protein Data Bank. The hot spots are identified by FTMap, a computational analogue of experimental fragment screening. Users of Kinase Atlas ( https://kinase-atlas.bu.edu ) may view summarized results for all structures of a particular kinase, such as which binding sites are present and how druggable they are, or they may view hot spot information for a particular kinase structure of interest.
Authors: Valerie Hindie; Adriana Stroba; Hua Zhang; Laura A Lopez-Garcia; Leila Idrissova; Stefan Zeuzem; Daniel Hirschberg; Francis Schaeffer; Thomas J D Jørgensen; Matthias Engel; Pedro M Alzari; Ricardo M Biondi Journal: Nat Chem Biol Date: 2009-08-30 Impact factor: 15.040
Authors: N Delhem; A Sabile; R Gajardo; P Podevin; A Abadie; M A Blaton; D Kremsdorf; L Beretta; C Brechot Journal: Oncogene Date: 2001-09-13 Impact factor: 9.867
Authors: Ece C Gaffarogullari; Larry R Masterson; Emily E Metcalfe; Nathaniel J Traaseth; Erica Balatri; Musa M Musa; Daniel Mullen; Mark D Distefano; Gianluigi Veglia Journal: J Mol Biol Date: 2011-06-29 Impact factor: 5.469
Authors: Vida Ravanmehr; Hannah Blau; Luca Cappelletti; Tommaso Fontana; Leigh Carmody; Ben Coleman; Joshy George; Justin Reese; Marcin Joachimiak; Giovanni Bocci; Peter Hansen; Carol Bult; Jens Rueter; Elena Casiraghi; Giorgio Valentini; Christopher Mungall; Tudor I Oprea; Peter N Robinson Journal: NAR Genom Bioinform Date: 2021-12-08
Authors: Maurice Michel; Evert J Homan; Elisée Wiita; Kia Pedersen; Ingrid Almlöf; Anna-Lena Gustavsson; Thomas Lundbäck; Thomas Helleday; Ulrika Warpman Berglund Journal: Front Chem Date: 2020-05-29 Impact factor: 5.221